Additionally, three candidate genes are associated with Breast cancer (DLL3, BRCA2, WNT2B), the mTOR signaling pathway (WNT2B, TELO2, TNFRSF1A), and Pathways in cancer (DLL3, BRCA2, WNT2B). This evidence concerns the gene TELO2 and cancer.